Akari Therapeutics PLC

Akari Therapeutics PLC financial statements

Akari Therapeutics PLC's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 17.3M10-K
Cash and equivalentsUSD 5.2M10-Q
Total debtUSD 754KEODHD

Akari Therapeutics PLC financials on 6ix · Akari Therapeutics PLC on 6ix